Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 25, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 2DT2 | Q8SPQ0 | Crystal structure of the complex formed between goat signalling protein with pentasaccharide at 2.9A resolution | |
| 2DT3 | Q8SPQ0 | Crystal structure of the complex formed between goat signalling protein and the hexasaccharide at 2.28 A resolution | |
| 2O92 | Q8SPQ0 | Crystal structure of a signalling protein (SPG-40) complex with tetrasaccharide at 3.0A resolution | |
| 2OLH | Q8SPQ0 | Crystal structure of a signalling protein (SPG-40) complex with cellobiose at 2.78 A resolution | |
| 4F4O | Q8SPS7 | Structure of the Haptoglobin-Haemoglobin Complex | |
| 3MBF | Q8SSM8 | Crystal structure of fructose bisphosphate aldolase from Encephalitozoon cuniculi, bound to fructose 1,6-bisphosphate | |
| 5F84 | Q8T045 | Crystal structure of Drosophila Poglut1 (Rumi) complexed with its glycoprotein product (glucosylated EGF repeat) and UDP | |
| 3AI0 | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with para-nitrophenyl-beta-D-glucopyranoside | |
| 3VIF | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with gluconolactone | |
| 3VIJ | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with glucose | |
| 3VIK | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with cellobiose | |
| 3VIL | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with salicin | |
| 3VIM | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 3VIN | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 6XRX | Q8T5C5 | Crystal structure of the mosquito protein AZ1 as an MBP fusion | |
| 6NRW | Q8T603 | Crystal structure of Dpr1 IG1 bound to DIP-eta IG1 | |
| 4G2U | Q8T8F4 | Crystal Structure Analysis of Ostertagia ostertagi ASP-1 | |
| 3K1L | Q8T913 | Crystal Structure of FANCL | |
| 4JNO | Q8T9N3 | Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140 (PfEBA-140/BAEBL) Region II in complex with sialyllactose | |
| 6VFU | Q8TAB3 | Crystal structure of human protocadherin 19 EC1-EC4 | |
| 5TIB | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Arg299:Ser306 fused to maltose binding protein | |
| 5TJ2 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Ser306 fused to maltose binding protein | |
| 5TJ4 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Pro306 fused to maltose binding protein | |
| 7CZQ | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P2B-1A10 | |
| 7CZU | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B | |
| 6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | |
| 6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | |
| 7CZR | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B | |
| 6ARU | Q8TCD0 | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | |
| 6ARU | Q8TCD0 | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | |
| 7CZS | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | |
| 7CZV | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 7D00 | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | |
| 1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN |
